The FDA has approved the SAPIEN 3 platform, a TAVR therapy, for patients with severe aortic stenosis without symptoms.

"Phase converters add another layer of complexity to any facility," writes Michael Baldauf in this Tech Tips article.

SAN DIEGO, April 30, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of a Phase 3 registrational program to evaluate the efficacy, safety and ...

Braintree® intends to submit results from the TRIUMpH Phase 3 studies to a high impact, peer reviewed journal along with presentation of this data at a leading gastroenterology conference in the ...

Most houses in the UK use a single-phase electricity supply. This means a maximum charging rate for electric cars of 7kW. Apart from private homes, however, much of this country is served by a ...

In bronchiectasis, neutrophilic inflammation is associated with an increased risk of exacerbations and disease progression. Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1 ...

Braintree ® intends to submit results from the TRIUMpH Phase 3 studies to a high impact, peer reviewed journal along with presentation of this data at a leading gastroenterology conference in the ...

Mark Huffman has been a consumer news reporter for ConsumerAffairs since 2004. He covers real estate, gas prices and the economy and has reported extensively on negative-option sales. He was ...

Emerge is the third Phase 3 study of MM120 ODT, with the Voyage and Panorama studies in GAD already underway. “In our Phase 2b study, MADRS score improvements after a single MM120 100 µg dose ...

Oak Hill plans to initiate a Phase 3 study in early 2026. We are excited to take on this program and are incredibly impressed by the rigorous research Roche has conducted, and the promising ...

In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments.